The authors identified VGF, SCG2, NPTX2, NPTXR, PDYN and PCSK1N as possible biomarker candidates, with the NPTX2, VGF, SCG2, PDYN panels being the most relevant for differentiating DLB from AD [70,71]. This evidence concerns the gene VGF and Alzheimer disease.